Lv41
420 积分 2023-12-02 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
3小时前
已完结
CircRNA-based, non-integrated, in vivo panCAR-mediated B cell immune resetting in mouse models and non-human primates
28天前
已完结
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles
1个月前
已完结
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
1个月前
已完结
Safety profile of RNAi nanomedicines
1个月前
已完结
High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics
1个月前
已完结
Adverse effects of intravenous LNP-mediated mRNA therapy in clinical trials: a systematic review and meta-analysis
1个月前
已完结
Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines
1个月前
已完结
Novel Complement C5 Small-interfering RNA Lipid Nanoparticle Prolongs Graft Survival in a Hypersensitized Rat Kidney Transplant Model
1个月前
已完结
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
1个月前
已完结
皖公网安备34019202002308
